Citation

Zehnder L, Bennett M, Meng J, Huang B, Ninkovic S, Wang F, Braganza J, Tatlock J, Jewell T, Zhou JZ, Burke B, Wang J, Maegley K, Mehta PP, Yin MJ, Gajiwala KS, Hickey MJ, Yamazaki S, Smith E, Kang P, Sistla A, Dovalsantos E, Gehring MR, Kania R, Wythes M, Kung PP.: Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide. J Med Chem, Volume 54 (9), 2011

Authors

Bennett M, Braganza J, Burke B, Dovalsantos E, Gajiwala KS, Gehring MR, Hickey MJ, Huang B, Jewell T, Kang P, Kania R, Kung PP., Maegley K, Mehta PP, Meng J, Ninkovic S, Sistla A, Smith E, Tatlock J, Wang F, Wang J, Wythes M, Yamazaki S, Yin MJ, Zehnder L, Zhou JZ

Journal

J Med Chem

Year

2011

DOI

10.1021/jm200128m

PubMed

21438541

Machine-readable

REST APIRDF